Literature DB >> 17063079

Prognostic significance of extent of ulceration in primary cutaneous melanoma.

Hege Grande Sarpa1, Kara Reinke, Ladan Shaikh, Stanley P L Leong, James R Miller, Richard W Sagebiel, Mohammed Kashani-Sabet.   

Abstract

Ulceration has been shown to be an adverse prognostic factor in primary cutaneous melanoma. However, the extent of ulceration required for histologic identification and biologic significance is unclear. We examined the impact of extent of ulceration on melanoma outcome in a cohort of 235 melanoma patients by evaluating the relationship between percentage of ulceration in the vertical growth phase of the primary tumor and 2 outcome parameters: sentinel lymph node status and overall survival. We measured the diameter of the ulcerated area in millimeters over the diameter of the entire vertical growth phase. There was a statistically significant relationship between increasing percentage of tumor ulceration and both sentinel lymph node status as well as overall survival, with a binary cut-off point of 2% for sentinel lymph node status and 5% for overall survival. The percentage of ulceration provides additional prognostic information in predicting sentinel lymph node status and in determining survival in melanoma patients. These results suggest that no more than minimal ulceration is required to have a prognostic impact on melanoma survival.

Entities:  

Mesh:

Year:  2006        PMID: 17063079     DOI: 10.1097/01.pas.0000213262.61855.7d

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

Review 1.  Predicting the outcome of melanoma: can we tell the future of a patient's melanoma?

Authors:  Oriol Yélamos; Pedram Gerami
Journal:  Melanoma Manag       Date:  2015-08-10

2.  Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma.

Authors:  So-Woon Kim; Young Il Kim; Bilal Mustafa; Mi-Ju Kim; Gowun Jeong; Sung-Min Ahn; Seok-Byung Lim; Chang Sik Yu; Jin Cheon Kim; Seung-Mo Hong; In Ja Park
Journal:  Mod Pathol       Date:  2020-07-24       Impact factor: 7.842

3.  Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas.

Authors:  Ellen H de Moll; Yichun Fu; Yingzhi Qian; Sara H Perkins; Shira Wieder; Sacha Gnjatic; Romain Remark; Sebastian G Bernardo; Marina Moskalenko; Jonathan Yao; Tammie Ferringer; Rui Chang; Jerry Chipuk; Basil A Horst; Miriam B Birge; Robert G Phelps; Yvonne M Saenger
Journal:  Cancer Immunol Immunother       Date:  2015-06-16       Impact factor: 6.968

4.  Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.

Authors:  Jan Zakrzewski; Laurel N Geraghty; Amy E Rose; Paul J Christos; Madhu Mazumdar; David Polsky; Richard Shapiro; Russell Berman; Farbod Darvishian; Eva Hernando; Anna Pavlick; Iman Osman
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

5.  Assessment of the Novel, Practical, and Prognosis-Relevant TNM Staging System for Stage I-III Cutaneous Melanoma.

Authors:  Di Hu; Zeming Liu; Sichao Chen; Yihui Huang; Wen Zeng; Wei Wei; Chao Zhang; Ling Zhou; Danyang Chen; Yiping Wu; Liang Guo
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

6.  The air liquid-interface, a skin microenvironment, promotes growth of melanoma cells, but not their apoptosis and invasion, through activation of mitogen-activated protein kinase.

Authors:  Chong Hong Yee; Shigehisa Aoki; Kazuyoshi Uchihashi; Aki Matsunobu; Fumio Yamasaki; Noriyuki Misago; Meihua Piao; Uemura Tetsuji; Nobuhisa Yonemitsu; Hajime Sugihara; Shuji Toda
Journal:  Acta Histochem Cytochem       Date:  2010-02-04       Impact factor: 1.938

7.  Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?

Authors:  Daniela Göppner; Martin Leverkus
Journal:  J Skin Cancer       Date:  2011-10-11

8.  A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts.

Authors:  Stefanie Meyer; Thomas J Fuchs; Anja K Bosserhoff; Ferdinand Hofstädter; Armin Pauer; Volker Roth; Joachim M Buhmann; Ingrid Moll; Nikos Anagnostou; Johanna M Brandner; Kristian Ikenberg; Holger Moch; Michael Landthaler; Thomas Vogt; Peter J Wild
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

9.  Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).

Authors:  Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

10.  Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center.

Authors:  Kenjiro Namikawa; Phyu P Aung; Jeffrey E Gershenwald; Denái R Milton; Victor G Prieto
Journal:  Cancer Med       Date:  2018-02-21       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.